![Joseph Wing On Tam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Wing On Tam
Amministratore Delegato presso DiagCor Bioscience, Inc. Ltd.
Provenienza dei contatti di primo grado di Joseph Wing On Tam
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
DiagCor Bioscience, Inc. Ltd.
![]() DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong.
4
| Holding Company | Medical Specialties | 4 |
Pangenia, Inc.
![]() Pangenia, Inc. Medical SpecialtiesHealth Technology Pangenia, Inc. provides genetic diagnostic and advisory services. Its services include genetic testing, parentage investigation, cancer testing, infectious disease identification, and various hereditary risk assessments. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong.
2
| Private Company | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Joseph Wing On Tam tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genelabs Technologies, Inc.
![]() Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Takara Bio USA, Inc.
![]() Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
Vivo Capital LLC
![]() Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Epitomics, Inc.
![]() Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
Monash University
![]() Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree | |
University of Hong Kong | College/University | Doctorate Degree | |
Indiana University | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
Kenson Ventures LLC
![]() Kenson Ventures LLC Investment ManagersFinance Kenson Ventures LLC (Kenson Ventures) is a venture capital firm founded in 1999 by Kenneth Fong. The firm is headquartered in in Palo Alto, California. | Investment Managers | Founder Private Equity Investor | |
Committee of 100
![]() Committee of 100 Investment Trusts/Mutual FundsMiscellaneous Committee of 100 provides grant making services. The non-profit company is based in New York, NY. The company was founded in 1988 by Henry Alfred Kissinger, Ieoh Ming Pei. | Investment Trusts/Mutual Funds | Director/Board Member | |
System Biosciences LLC
![]() System Biosciences LLC Miscellaneous Commercial ServicesCommercial Services System Biosciences LLC develops proprietary siRNA and microRNA technologies. Its products include lentiviral technology, genome engineering, molecular tools, stem cell research, exosome research, microrna research and immunology. The company was founded by Kenneth Fong in July 2002 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Founder | |
Apexigen America, Inc.
![]() Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Chairman | |
HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED | Medical Specialties | Director/Board Member | |
Zhejiang Thunderbio Innovation Ltd. | Chief Executive Officer | ||
APEXIGEN, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Hong Kong | 3 |
Australia | 2 |
Cina | 2 |
Settori
Health Technology | 7 |
Consumer Services | 5 |
Finance | 3 |
Health Services | 2 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 9 |
Founder | 3 |
Chief Executive Officer | 3 |
Doctorate Degree | 3 |
Corporate Officer/Principal | 3 |
Contatti più connessi
Insiders | |
---|---|
Kenneth Fong | 11 |
Joseph C. C. Huang | 5 |
Kwok Fai Joseph Chow | 5 |
Lucy Lai | 1 |
Desmond Hau | 1 |
Anthony Wong | 1 |
- Borsa valori
- Insiders
- Joseph Wing On Tam
- Connessioni Società